Association·arcadia
TAK-063 recovers cpc1-1 motility
TAK-063 treatment improved motility in cpc1-1 mutant cells
Confidence
100%
active
Evidence Quote
“cpc1-1 had a clear recovery in wild-type motility behaviors when treated with TAK-063”
Relationship
TAK063 increases Chlamydomonas reinhardtii motility
Connections (6)
Drug-specific effects on mutant motility phenotypesInferenceChain
Microchamber components enable microscopyAssociation
Mechanistic reasoning on flagellar mutant phenotypes and motilityInferenceChain
Mechanistic reasoning on drug effects modulating Chlamydomonas motilityInferenceChain
Reasoning on drug-specific effects on mutant motility phenotypesInferenceChain
Reasoning on flagellate motility assessment methods and effectsInferenceChain